5O76
Structure of phosphoY371 c-CBL in complex with ZAP70-peptide and UbV.pCBL ubiquitin variant
5O76 の概要
エントリーDOI | 10.2210/pdb5o76/pdb |
分子名称 | E3 ubiquitin-protein ligase CBL, Tyrosine protein kinase ZAP70 peptide, UbV.pCBL ubiquitin variant, ... (6 entities in total) |
機能のキーワード | e3 ring ligase, ubiquitin variant, ligase |
由来する生物種 | Homo sapiens (Human) 詳細 |
細胞内の位置 | Cytoplasm: P22681 |
タンパク質・核酸の鎖数 | 6 |
化学式量合計 | 111580.85 |
構造登録者 | |
主引用文献 | Gabrielsen, M.,Buetow, L.,Nakasone, M.A.,Ahmed, S.F.,Sibbet, G.J.,Smith, B.O.,Zhang, W.,Sidhu, S.S.,Huang, D.T. A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Mol. Cell, 68:456-470.e10, 2017 Cited by PubMed Abstract: RING and U-box E3 ubiquitin ligases regulate diverse eukaryotic processes and have been implicated in numerous diseases, but targeting these enzymes remains a major challenge. We report the development of three ubiquitin variants (UbVs), each binding selectively to the RING or U-box domain of a distinct E3 ligase: monomeric UBE4B, phosphorylated active CBL, or dimeric XIAP. Structural and biochemical analyses revealed that UbVs specifically inhibited the activity of UBE4B or phosphorylated CBL by blocking the E2∼Ub binding site. Surprisingly, the UbV selective for dimeric XIAP formed a dimer to stimulate E3 activity by stabilizing the closed E2∼Ub conformation. We further verified the inhibitory and stimulatory functions of UbVs in cells. Our work provides a general strategy to inhibit or activate RING/U-box E3 ligases and provides a resource for the research community to modulate these enzymes. PubMed: 29053960DOI: 10.1016/j.molcel.2017.09.027 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.473 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード